Home/Novartis/Frans van Houten
FV

Frans van Houten

Board Member

Novartis

Novartis Pipeline

DrugIndicationPhase
Cosentyx®Pediatric Hidradenitis Suppurativa (12+)Approved
Pan-mutant-selective PI3Kα inhibitorBreast CancerAcquisition